# Top 20 Life Science Startup Investors in Singapore in June 2026 ## Eisai - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 2 - Stages: Series A, Series C - Focus: Biotechnology, Medical, Health Care Eisai is a pharmaceutical company that researches and delivers medicines for patients. ## EDBI - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 2 - Stages: Series C, Series B, Series D - Focus: Biotechnology, Software, Health Care EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies. ## Hana Financial Investment - Type: VC Fund - Location: Seoul, Seoul-t'ukpyolsi, South Korea - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: Information Technology, Biotechnology, Software Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services ## The Venture Collective - Type: VC Fund - Location: New York, New York, United States - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Health Care, Biotechnology, Artificial Intelligence TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders. ## Temasek Holdings - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 1 - Stages: Series B, Series C, Series D - Focus: Biotechnology, Health Care, Software Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion. ## KT Investment - Type: VC Fund - Location: Seoul, Seoul-t'ukpyolsi, South Korea - Relevant deals: 1 - Stages: Series A, Series B, Series C - Focus: Artificial Intelligence, Software, Information Technology KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future. ## Nestle - Type: VC Fund - Location: Vevey, Vaud, Switzerland - Relevant deals: 1 - Stages: Corporate Round, Grant - Focus: Food and Beverage, Health Care, Food Processing Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries. ## Lightstone Ventures - Type: VC Fund - Location: Menlo Park, California, United States - Relevant deals: 1 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space. ## M Capital Partners - Type: VC Fund - Location: Toulouse, Midi-Pyrenees, France - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Software, Food and Beverage M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies. ## Anzu Partners - Type: VC Fund - Location: Washington, District of Columbia, United States - Relevant deals: 1 - Stages: Series A, Series B - Focus: Biotechnology, Software, Manufacturing Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures. ## K3 Ventures - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 1 - Stages: Series A, Seed - Focus: Financial Services, FinTech, Software K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong. ## SK Securities - Type: VC Fund - Location: Yongdungpo, Seoul-t'ukpyolsi, South Korea - Relevant deals: 1 - Stages: Series A, Seed, Series B - Focus: Apps, Health Care, Information Technology SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955. ## Partners Investment - Type: VC Fund - Location: Seoul, Seoul-t'ukpyolsi, South Korea - Relevant deals: 1 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Software As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies. ## Amgen Ventures - Type: VC Fund - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Therapeutics Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts. ## UTEC - The University of Tokyo Edge Capital Partners - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo. ## Seeds Capital - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 1 - Stages: Seed, Series A, Series B - Focus: Software, Biotechnology, Health Care Catalysing smart monies into Singapore-based, early-stage technology startups. ## KB Financial Group - Type: VC Fund - Location: Seoul, Seoul-t'ukpyolsi, South Korea - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: Software, Financial Services, SaaS KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services. ## Openspace Capital - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: E-Commerce, Financial Services, Software Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life. ## Prox Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 1 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Health Care Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health. ## Altara Ventures - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: FinTech, Software, Financial Services Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co